Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Stieglitz

Showing results (31-40 of 81) with videos related to

Pageof 9
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Scientific Reports|August 30, 2022
Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemiaTakahiro Imaizumi, Julia Meyer, Manabu Wakamatsu, et al.
Frontiers in Immunology|October 10, 2024
Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapyClaire Johns, Courtney Erickson, Ashley Jacobs, et al.
Journal of Pediatric Hematology/Oncology|August 21, 2020
NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMMLAstrid Behnert, Alex G Lee, Elizabeth P Young, et al.
Cancer Reports (Hoboken, N.J.)|November 7, 2023
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patientsSavannah S Shumock, William C Temple, Amanda Marinoff, et al.
Pediatric Blood & Cancer|January 9, 2025
Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic MalignanciesAmanda E Marinoff, Allyson Thrall, Kathryn Aaronson, et al.
Pediatric Blood & Cancer|December 23, 2021
Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literatureAstrid Wintering, Stephen Smith, Beng Fuh, et al.
Blood|June 3, 2026
Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic LeukemiaSanthosh Kumar Pasupuleti, Baskar Ramdas, Kanaka Sai Ram Padam, et al.
Nature Communications|December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemiaElliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2020
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic LeukemiaMaximilian Schönung, Julia Meyer, Peter Nöllke, et al.
Pageof 9

Showing results (31-40 of 81) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 5, 2023
Potential clinical use of azacitidine and MEK inhibitor combination therapy in PTPN11-mutated juvenile myelomonocytic leukemiaSanthosh Kumar Pasupuleti, Karen Chao, Baskar Ramdas, et al.
Scientific Reports|August 30, 2022
Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemiaTakahiro Imaizumi, Julia Meyer, Manabu Wakamatsu, et al.
Frontiers in Immunology|October 10, 2024
Case report: sub-clinical extramedullary B-ALL in the setting of relapse following targeted therapyClaire Johns, Courtney Erickson, Ashley Jacobs, et al.
Journal of Pediatric Hematology/Oncology|August 21, 2020
NUP98-NSD1 Driven MDS/MPN in Childhood Masquerading as JMMLAstrid Behnert, Alex G Lee, Elizabeth P Young, et al.
Cancer Reports (Hoboken, N.J.)|November 7, 2023
Pre-and post-HSCT use of TKI therapy for fusion-driven B-ALL: A case series of five pediatric, adolescent and young adult patientsSavannah S Shumock, William C Temple, Amanda Marinoff, et al.
Pediatric Blood & Cancer|January 9, 2025
Thrombopoietin Receptor Agonists for Thrombocytopenia in Pediatric Hematologic MalignanciesAmanda E Marinoff, Allyson Thrall, Kathryn Aaronson, et al.
Pediatric Blood & Cancer|December 23, 2021
Therapy-related myeloid neoplasms resembling juvenile myelomonocytic leukemia: a case series and review of the literatureAstrid Wintering, Stephen Smith, Beng Fuh, et al.
Blood|June 3, 2026
Therapeutic Targeting of IL-17A-Driven PTGS2/NLRP3 Inflammasome Activation in Juvenile Myelomonocytic LeukemiaSanthosh Kumar Pasupuleti, Baskar Ramdas, Kanaka Sai Ram Padam, et al.
Nature Communications|December 21, 2017
Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemiaElliot Stieglitz, Tali Mazor, Adam B Olshen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2020
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic LeukemiaMaximilian Schönung, Julia Meyer, Peter Nöllke, et al.
Pageof 9